Shire Human Genetic Therapies, Inc. - Net Worth and Insider Trading
Shire Human Genetic Therapies, Inc. Net Worth
The estimated net worth of Shire Human Genetic Therapies, Inc. is at least $0 dollars as of 2024-12-28. Shire Human Genetic Therapies, Inc. is the 10% Owner of Translate Bio Inc and owns about 0 shares of Translate Bio Inc (TBIO) stock worth over $0. Details can be seen in Shire Human Genetic Therapies, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shire Human Genetic Therapies, Inc. has not made any transactions after 2020-06-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shire Human Genetic Therapies, Inc. owns 1 companies in total, including Translate Bio Inc (TBIO) .
Insider Ownership Summary of Shire Human Genetic Therapies, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TBIO | Translate Bio Inc | 2020-06-30 | 10 percent owner |
Shire Human Genetic Therapies, Inc. Latest Holdings Summary
Shire Human Genetic Therapies, Inc. currently owns a total of 1 stock. Shire Human Genetic Therapies, Inc. owns 0 shares of Translate Bio Inc (TBIO) as of June 30, 2020, with a value of $0.
Latest Holdings of Shire Human Genetic Therapies, Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TBIO | Translate Bio Inc | 2020-06-30 | 0 | 37.36 | 0 |
Holding Weightings of Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Shire Human Genetic Therapies, Inc. has made a total of 3 transactions in Translate Bio Inc (TBIO) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Translate Bio Inc is the sale of 6,824,992 shares on June 30, 2020, which brought Shire Human Genetic Therapies, Inc. around $141 Million.
Insider Trading History of Shire Human Genetic Therapies, Inc.
- 1
Shire Human Genetic Therapies, Inc. Trading Performance
Shire Human Genetic Therapies, Inc. Ownership Network
Shire Human Genetic Therapies, Inc. Owned Company Details
What does Translate Bio Inc do?
Who are the key executives at Translate Bio Inc?
Shire Human Genetic Therapies, Inc. is the 10 percent owner of Translate Bio Inc. Other key executives at Translate Bio Inc include director & Chief Executive Officer & other: President Renaud Ronald C Jr , Chief Operating Officer & CLO & other: Secretary Paul D. Burgess , and 10 percent owner Takeda Pharmaceutical Co Ltd .
Translate Bio Inc (TBIO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Translate Bio Inc (TBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Translate Bio Inc (TBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Translate Bio Inc (TBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Translate Bio Inc Insider Transactions
Shire Human Genetic Therapies, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Shire Human Genetic Therapies, Inc.. You might contact Shire Human Genetic Therapies, Inc. via mailing address: 300 Shire Way Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
